LncRNA TUG1 Promoted Viability and Associated with Gemcitabine Resistant in Pancreatic Ductal Adenocarcinoma

Overview

Journal J Pharmacol Sci

Specialty Pharmacology

Date 2018 Jul 2

PMID 29960845

Citations 18

Authors

Fan Yang

Xiaofang Li

Lingjuan Zhang

Lina Cheng

Xiuling Li

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the underlying mechanism of lncRNA TUG1 in pancreatic ductal adenocarcinoma (PDAC).

Methods: The expression of TUG1 was defined by qRT-PCR. The apoptotic cells were detected by flow cytometry assay. The cell migration and invasion were measured by scratch assay and Transwell assay. The level of ERK pathway was detected using Western blot.

Results: Compared with normal tissues and cells, the expression of TUG1 was up-regulated in pancreatic cancer tissue and cells. Meanwhile, knockdown of TUG1 could promote PDAC cells apoptosis and inhibit PDAC cells viability, migration and invasion. In addition, overexpression of TUG1 enhanced the gemcitabine chemoresistance of PDAC cells. Surprisingly, gemcitabine combined with SCH772984 (a suppressor of ERK pathway) could reverse the drug resistance resulted from overexpression of TUG1.

Conclusion: TUG1 promoted the viability of PDAC cells and enhanced its resistance of gemcitabine.

Citing Articles

The Role of Long Noncoding RNAs in Progression of Leukemia: Based on Chromosomal Location.

Sabaghi F, Sadat S, Mirsaeedi Z, Salahi A, Vazifehshenas S, Kesh N Microrna. 2024; 13(1):14-32.

PMID: 38275047 DOI: 10.2174/0122115366265540231201065341.

Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells.

Maharati A, Samsami Y, Latifi H, Tolue Ghasaban F, Moghbeli M Cancer Cell Int. 2023; 23(1):168.

PMID: 37580768 PMC: 10426205. DOI: 10.1186/s12935-023-03004-7.

Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.

Wei L, Sun J, Wang X, Huang Y, Huang L, Han L Front Cell Dev Biol. 2023; 11:1226639.

PMID: 37560164 PMC: 10407809. DOI: 10.3389/fcell.2023.1226639.

Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.

Liu Q, Zhao H, Guo Y, Zhang K, Shang F, Liu T J Healthc Eng. 2022; 2022:7904982.

PMID: 36105715 PMC: 9467764. DOI: 10.1155/2022/7904982.

Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance.

Li J, Hou S, Ye Z, Wang W, Hu X, Hang Q Cancers (Basel). 2022; 14(9).

PMID: 35565245 PMC: 9100048. DOI: 10.3390/cancers14092115.